ECHA proposes to restrict intentionally added microplastics
ECHA has submitted a restriction proposal for microplastic particles that are intentionally added to mixtures used by consumers or professionals. If adopted, the restriction could reduce the amount of microplastics released to the environment in the EU by about 400 thousand tonnes over 20 years.
The European Union Observatory for Nanomaterials (EUON) conducts up to three studies every year to address knowledge gaps relating to nanomaterials that are of interest to the general public and the research community. We are now looking for suggestions for topics that could be addressed in its upcoming studies. Submit your proposal by 7 February 2019.
Provide feedback on the EU nanomaterials observatory
The European Observatory for Nanomaterials (EUON) provides information on nanomaterials to a wide audience on subjects ranging from safety to innovation. It also covers the existing EU legislation on nanomaterials and the presence and uses of specific substances on the EU market.
We would like to hear your views on how the EUON is performing and how it could be developed to better meet your needs. Have your say by completing our short questionnaire.
A new practical guide on how to report changes in identity under REACH and CLP has been published. The guide replaces ‘Practical guide 8: How to report changes in identity of legal entities’. It is currently available in English, but translations are expected at a later date.
On 23 January, the European Court of Justice issued a judgment dismissing in its entirety an appeal brought by DEZA against the General Court’s judgment in case T-115/15 concerning the substance bis(2-ethylhexyl) phthalate (DEHP) (EC 204-211-0, CAS 117-81-7). In the case, the General Court dismissed DEZA’s action for annulment against ECHA’s decision to identify DEHP as an endocrine disruptor to the environment.
The European Court of Justice confirmed that ECHA can supplement existing Candidate List entries of a substance with new properties. Furthermore, the Court considered that ECHA could identify DEHP as a substance of very high concern (SVHC) without waiting for the outcome of various other regulatory and policy processes addressing endocrine disruptors.
The practical guide 'How to act in dossier evaluation' explains how ECHA processes dossiers and how registrants should act after receiving the draft or adopted decision. The guide clarifies the revised dossier evaluation decision practices, where from 1 January 2019, decisions are sent to all non-compliant registrants of a substance. It also highlights the opportunities and obligations for registrants in making sure that their dossier complies with REACH.
Targeted public consultations on harmonised classification and labelling
ECHA has launched targeted public consultations on additional information provided for two proposals for harmonised classification and labelling.
Study reports containing additional information on toxicity to reproduction have been submitted by ECHA for the substance flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboximide (EC -, CAS 103361-09-7).
The lead registrant of the substance 1-isopropyl-4-methylbenzene; p-cymene(EC 202-796-7, CAS 99-87-6) has indicated the availability of an unpublished acute toxicity study in Daphnia magna that would potentially change the classification proposal for hazards to the aquatic environment. The study has been provided in the form of a robust study summary in IUCLID format.
Interested parties are invited to submit their comments to both targeted public consultations by 11 February 2019.
Decision concerning the joint submission obligation published
In case A-005-2017 an appeal was brought against an ECHA communication addressed to all registrants of the substance tetrakis(hydroxymethyl)phosphonium chloride, oligomeric reaction products with urea (EC 500-057-6). According to ECHA’s communication, the joint submission obligation had been breached because separate registrations had been submitted for the same substance.
The Board of Appeal considered that the communication was in fact a decision and annulled it on the grounds that ECHA had not followed the procedures set out in REACH. The Board of Appeal found that, as a result, the Appellant’s right to be heard had been breached.
More targeted capacity building for EU candidate countries
ECHA continues to support the accession process of EU candidate countries with capacity building through bilateral visits, specific trainings and events. To increase the impact of these efforts, an in-depth assessment of the status and needs of two candidate countries, Montenegro and Serbia, will be carried out between 2019 and 2021.
Next week ECHA will publish a communications package to help all companies placing chemical substances on the EU market to prepare for the UK’s withdrawal from the EU. The package will include new Q&As and step-by-step instructions for using the ‘Brexit window’ for UK-based companies to transfer their REACH registrations.